CANN:CA:CNSX-Heritage Cannabis Holdings Corp (CAD)

COMMON STOCK | Drug Manufacturers-Specialty & Generic | CNSX

Last Closing Price

CAD 0.07

Change

-0.01 (-6.67)%

Market Cap

CAD 0.06B

Volume

1.39M

Avg Analyst Target

CAD 0.20 (+185.71%)

Avg User Target

CAD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


Heritage Cannabis Holdings Corp (CANN) Stock Analysis:
Based on the Heritage Cannabis Holdings Corp stock forecasts from 1 analysts, the average analyst target price for Heritage Cannabis Holdings Corp is CAD 0.20 over the next 12 months. Heritage Cannabis Holdings Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Heritage Cannabis Holdings Corp is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Heritage Cannabis Holdings Corp’s stock price was CAD 0.07. Heritage Cannabis Holdings Corp’s stock price has changed by -0.01 % over the past week, +0.01 % over the past month and -39.13 % over the last year.

About

Heritage Cannabis Holdings Corp., through its subsidiaries, operates as a cannabinoid company that focuses on the production and sale of medical and recreational hemp-based and cannabis-based products and services in Canada and the United States. It offers extraction services; an ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-12-03 )

Largest Industry Peers for Drug Manufacturers-Specialty & Generic

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CURA:CA Curaleaf Holdings Inc

-0.10 (-0.83%)

CAD8.77B N/A 33.51
GTII:CA Green Thumb Industries Inc

-0.27 (-1.01%)

CAD6.34B 61.35 20.28
TRUL:CA Trulieve Cannabis Corp

+0.50 (+1.49%)

CAD6.30B 37.67 21.63
VRNO:CA Verano Holdings Corp

+0.65 (+4.75%)

CAD2.95B 19.12 21.82
CL:CA Cresco Labs Inc

-0.19 (-1.80%)

CAD2.92B N/A 20.98
HARV:CA Harvest Health & Recreation In..

N/A

CAD1.65B N/A 122.88
TER:CA TerrAscend Corp

-0.17 (-2.08%)

CAD1.45B N/A 82.95
CCHW:CA Columbia Care Inc

-0.33 (-7.99%)

CAD1.41B N/A 127.53
AYR-A:CA Ayr Wellness Inc

-0.67 (-3.38%)

CAD1.38B N/A N/A
JUSH:CA Jushi Holdings Inc

+0.02 (+0.41%)

CAD1.02B N/A N/A

ETFs Containing CANN:CA

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Drug Manufacturers-Specialty & Generic)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -48.15% 44% F 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -48.15% 44% F 28% F
Trailing 12 Months  
Capital Gain -39.13% 42% F 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -39.13% 42% F 32% F
Trailing 5 Years  
Capital Gain 133.33% 77% C+ 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 133.33% 77% C+ 70% C-
Average Annual (5 Year Horizon)  
Capital Gain -15.03% 29% F 14% F
Dividend Return N/A 62% D- 74% C
Total Return -15.03% 29% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 35.60% 71% C- 72% C-
Risk Adjusted Return -42.22% 31% F 21% F
Market Capitalization 0.06B 76% C 87% B+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Drug Manufacturers-Specialty & Generic)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 0.61 85% B 90% A-
Price / Cash Flow Ratio -8.42 61% D- 44% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -23.38% 76% C 81% B-
Return on Invested Capital -7.27% 76% C 75% C
Return on Assets -8.48% 68% D+ 81% B-
Debt to Equity Ratio 6.02% 53% F 35% F
Technical Ratios  
Short Ratio 0.30 66% D 57% F
Short Percent N/A N/A N/A N/A N/A
Beta 0.04 86% B 82% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Discussions

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector